RB Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$5.41M |
| 2 |
Walmart Inc
WMT
|
+$2.65M |
| 3 |
Deere & Co
DE
|
+$1.56M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$1.14M |
| 5 |
Walt Disney
DIS
|
+$780K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$4.79M |
| 2 |
Coca-Cola
KO
|
+$1.6M |
| 3 |
Microsoft
MSFT
|
+$764K |
| 4 |
Johnson & Johnson
JNJ
|
+$656K |
| 5 |
Huntington Bancshares
HBAN
|
+$510K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Consumer Discretionary | 12.8% |
| 3 | Financials | 12.15% |
| 4 | Communication Services | 8.97% |
| 5 | Consumer Staples | 7.72% |
Similar funds
RB Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, RB Capital Management held 144 positions worth $175M, up 12% from $156M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
RB Capital Management deployed $6.5M of net new capital in Q4 2019, opening 10 new positions and adding to 81 existing holdings. Its largest new stake was iShares Biotechnology ETF: 10,202 shares worth $220K.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $4.79M trimmed.
- RB Capital Management's largest Q4 2019 buy was iShares Biotechnology ETF: 10,202 shares worth $220K.
- RB Capital Management added most to Lockheed Martin in Q4 2019, an estimated $5.41M increase.
- RB Capital Management's biggest Q4 2019 reduction was Starbucks, cutting an estimated $4.79M.
- RB Capital Management fully exited Taubman Centers Inc. in Q4 2019, selling an estimated $205K.
- RB Capital Management's ten largest holdings make up 43% of its $175M portfolio in Q4 2019.
- RB Capital Management opened 10 new positions and closed 4 in Q4 2019.
- RB Capital Management's portfolio value rose 12% quarter-over-quarter to $175M.
Based on RB Capital Management's 13F filing for Q4 2019, filed 11 Feb 2020.